• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺疾病筛查:推荐声明。

Screening for thyroid disease: recommendation statement.

出版信息

Ann Intern Med. 2004 Jan 20;140(2):125-7. doi: 10.7326/0003-4819-140-2-200401200-00014.

DOI:10.7326/0003-4819-140-2-200401200-00014
PMID:14734336
Abstract

This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for thyroid disease and updates the 1996 recommendations on this topic. The complete USPSTF recommendation statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (http://www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (http://www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358-9295; e-mail, ahrqpubs.gov). The complete information on which this statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned. The recommendation statement and article are also available in print through the Agency for Healthcare Research and Quality Publications Clearinghouse.

摘要

本声明总结了美国预防服务工作组(USPSTF)目前关于甲状腺疾病筛查的建议,并更新了1996年关于该主题的建议。关于该主题的完整USPSTF建议声明,包括对支持证据的简要回顾,可通过USPSTF网站(http://www.preventiveservices.ahrq.gov)、国家指南库(http://www.guideline.gov)获取,也可通过医疗保健研究与质量机构出版物交换中心以印刷品形式获取(电话:800-358-9295;电子邮件:ahrqpubs.gov)。本声明所依据的完整信息,包括证据表和参考文献,可在本期的随附文章以及上述网站上的证据摘要和系统证据综述中获取。建议声明和文章也可通过医疗保健研究与质量机构出版物交换中心以印刷品形式获取。

相似文献

1
Screening for thyroid disease: recommendation statement.甲状腺疾病筛查:推荐声明。
Ann Intern Med. 2004 Jan 20;140(2):125-7. doi: 10.7326/0003-4819-140-2-200401200-00014.
2
Screening for obesity in adults: recommendations and rationale.成人肥胖筛查:建议与依据
Ann Intern Med. 2003 Dec 2;139(11):930-2. doi: 10.7326/0003-4819-139-11-200312020-00012.
3
Screening for type 2 diabetes mellitus in adults: recommendations and rationale.成人2型糖尿病筛查:建议与依据
Ann Intern Med. 2003 Feb 4;138(3):212-4. doi: 10.7326/0003-4819-138-3-200302040-00014.
4
Lung cancer screening: recommendation statement.肺癌筛查:推荐声明。
Ann Intern Med. 2004 May 4;140(9):738-9. doi: 10.7326/0003-4819-140-9-200405040-00014.
5
Screening for coronary heart disease: recommendation statement.冠心病筛查:推荐声明。
Ann Intern Med. 2004 Apr 6;140(7):569-72. doi: 10.7326/0003-4819-140-7-200404060-00001.
6
Screening for family and intimate partner violence: recommendation statement.家庭及亲密伴侣暴力筛查:推荐声明
Ann Intern Med. 2004 Mar 2;140(5):382-6. doi: 10.7326/0003-4819-140-5-200403020-00014.
7
Screening for colorectal cancer: recommendation and rationale.结直肠癌筛查:建议及依据。
Ann Intern Med. 2002 Jul 16;137(2):129-31. doi: 10.7326/0003-4819-137-2-200207160-00014.
8
Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement.初级保健中用于减少酒精滥用的筛查和行为咨询干预措施:推荐声明。
Ann Intern Med. 2004 Apr 6;140(7):554-6. doi: 10.7326/0003-4819-140-7-200404060-00016.
9
Screening for suicide risk: recommendation and rationale.自杀风险筛查:建议与依据。
Ann Intern Med. 2004 May 18;140(10):820-1. doi: 10.7326/0003-4819-140-10-200405180-00022.
10
Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.预防癌症和心血管疾病的常规维生素补充:建议及理论依据
Ann Intern Med. 2003 Jul 1;139(1):51-5. doi: 10.7326/0003-4819-139-1-200307010-00013.

引用本文的文献

1
Hashimoto Thyroiditis beyond Cytology: A Correlation between Cytological, Hormonal, Serological, and Radiological Findings.超越细胞学的桥本甲状腺炎:细胞学、激素、血清学及影像学检查结果之间的相关性
J Thyroid Res. 2023 Jun 19;2023:5707120. doi: 10.1155/2023/5707120. eCollection 2023.
2
Clinical significance of thyroid hormone and antibodies in patients with idiopathic interstitial pneumonia.特发性间质性肺炎患者甲状腺激素及抗体的临床意义
J Thorac Dis. 2020 Mar;12(3):522-537. doi: 10.21037/jtd.2020.01.02.
3
Significance of Anti-TPO as an Early Predictive Marker in Thyroid Disease.
抗甲状腺过氧化物酶作为甲状腺疾病早期预测标志物的意义
Autoimmune Dis. 2019 Jul 28;2019:1684074. doi: 10.1155/2019/1684074. eCollection 2019.
4
Evaluation of the Female Patients with Subclinical Hypothyroidism by Brainstem Auditory Evoked Potentials: Case-Control Study.脑干听觉诱发电位对亚临床甲状腺功能减退女性患者的评估:病例对照研究
J Clin Diagn Res. 2017 Jun;11(6):CC13-CC16. doi: 10.7860/JCDR/2017/25604.9989. Epub 2017 Jun 1.
5
Prevalence and Determinants of True Thyroid Dysfunction Among Pediatric Referrals for Abnormal Thyroid Function Tests.甲状腺功能检查异常的儿科转诊患者中真正甲状腺功能障碍的患病率及影响因素
Glob Pediatr Health. 2016 May 5;3:2333794X16646701. doi: 10.1177/2333794X16646701. eCollection 2016.
6
Thyroid dysfunction in an adult female population: A population-based study of Latin American Vertebral Osteoporosis Study (LAVOS) - Puerto Rico site.成年女性人群中的甲状腺功能障碍:基于拉丁美洲椎体骨质疏松症研究(LAVOS)-波多黎各站点的一项人群研究。
P R Health Sci J. 2013 Jun;32(2):57-62.
7
Effects of thyroid dysfunction on lipid profile.甲状腺功能障碍对血脂谱的影响。
Open Cardiovasc Med J. 2011;5:76-84. doi: 10.2174/1874192401105010076. Epub 2011 Feb 24.
8
Asymptomatic hyperthyroidism in older adults: is it a distinct clinical and laboratory entity?老年人无症状性甲状腺功能亢进症:它是一种独特的临床和实验室实体吗?
Drugs Aging. 2008;25(5):371-80. doi: 10.2165/00002512-200825050-00002.
9
Patient difficulty using tablet computers to screen in primary care.患者在初级保健中使用平板电脑进行筛查存在困难。
J Gen Intern Med. 2008 Apr;23(4):476-80. doi: 10.1007/s11606-007-0500-1.
10
Subclinical hypothyroidism: the state of the art.亚临床甲状腺功能减退症:当前的技术水平
J Endocrinol Invest. 2008 Jan;31(1):79-84. doi: 10.1007/BF03345571.